DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical PreparationsMost-boughtAI cap-ex
LGND
LIGAND PHARMACEUTICALS INC
368 institutions still hold LIGAND PHARMACEUTICALS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 53220K504·Pharmaceutical Preparations·368 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
368 institutions reported LGND in Q1 2026. BlackRock, Inc. leads at 21.4% of the visible book. +16 net new institutions vs prior quarter — accumulation reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 19
348 more holders available. Log in →